
The Federal Drug Administration (FDA) has approved a new injectable treatment for HIV pre-exposure prevention, or PrEP. The drug, Apretude, is approved for at-risk adults and adolescents who weigh at…
The Federal Drug Administration (FDA) has approved a new injectable treatment for HIV pre-exposure prevention, or PrEP. The drug, Apretude, is approved for at-risk adults and adolescents who weigh at…